icd code for nuswab

Vaginitis (VG), Herpes Simplex Virus (HSV), NuSwab® TEST: 180071 Test number copied CPT: 87529 (x2); 87661; 87798 (x3); 87801

Full Answer

What is the CPT code for a vaginal swab test?

Result Code Name UofM Result LOINC; 180021: NuSwab Vaginitis Plus (VG+) 92703-8: 180061: Atopobium vaginae: Score: 69565-0: 180021: NuSwab Vaginitis Plus (VG+) 92703-8: 180062: BVAB 2: Score: 69566-8: 180021: NuSwab Vaginitis Plus (VG+) 92703-8: 180063: Megasphaera 1: Score: 69567-6: 180021: NuSwab Vaginitis Plus (VG+) 92703-8: 180056: Candida albicans, …

What is the ICD 10 code for urinalysis?

Oct 01, 2021 · N77.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Vaginitis, vulvitis and vulvovaginitis in dis classd elswhr. The 2022 edition of ICD-10-CM N77.1 became effective on October 1, 2021.

What is the ICD 10 code for excluded note?

Vaginitis Plus (VG+), NuSwab® Additional Information: UFHPL Epic order code: LAB5321. CPT Code(s): 87481 (x 2), 87491, 87591, 87661, 87798 (x 3) ... Also used in the diagnosis of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infections. Methodology:

What is the ICD 10 code for nephrotic syndrome?

Oct 01, 2021 · N76.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM N76.0 became effective on October 1, 2021. This is the American ICD-10-CM version of N76.0 - other international versions of ICD-10 N76.0 may differ. Applicable To.

What ICD 10 code for clue cells?

What is the ICD 10 code for N76?

What is diagnosis code z91 81?

What is diagnosis code g4700?

What is the correct ICD 10 code for leukocytosis?

What is vulvar inflammation?

Can Z91 81 be a primary diagnosis?

What is the ICD-10-CM code for osteoporosis?

What is the ICD-10 code for syncope and collapse?

What does F41 9 mean?

What does F43 23 mean?

Is the F32 9 billable?

Collection Procedure

Vaginal Swab: Collect a vaginal fluid sample using a Gen-Probe ® Aptima ® swab by contacting the swab to the lower third of the vaginal wall and rotating the swab for 10 to 30 seconds to absorb fluid. Immediately place the swab into the transport tube and carefully break the swab shaft against the side of the tube. Screw on the cap on tightly.

Specimen Requirements

Storage: Maintain specimen at room temperature or refrigerate (2°C to 30°C).

Use

This test is intended to be used as an aid to the diagnosis of bacterial vaginosis (BV) in women with a clinical presentation consistent with this disorder.

What does "type 1 excludes" mean?

It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as Z13.811. A type 1 excludes note is for used for when two conditions cannot occur together , such as a congenital form versus an acquired form of the same condition.

What is a screening test?

Screening is the testing for disease or disease precursors in asymptomatic individuals so that early detection and treatment can be provided for those who test positive for the disease. Type 1 Excludes. encounter for diagnostic examination-code to sign or symptom.

Test Includes

Bacterial vaginosis ( Atopobium vaginae, BVAB 2; Megasphaera 1); Candida albicans; Candida glabrata; Candida tropicalis; Candida parapsilosis; Candida lusitaniae; Candida krusei; Chlamydia trachomatis; Neisseria gonorrhoeae; Trichomonas vaginalis

Expected Turnaround Time

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Collection

Vaginal swab: Collect vaginal fluid sample using the Gen-Probe® Aptima® swab by contacting the swab to the lower third of the vaginal wall and rotating the swab for 10 to 30 seconds to absorb fluid. Immediately place the swab into the transport tube, and carefully break the swab shaft against the side of the tube. Screw the cap on tightly.

Causes for Rejection

Incorrect patient identification; unlabeled specimen; inappropriate specimen transport conditions; specimen leaked in transit; specimen in expired transport or incorrect transport device; specimens with inappropriate source for test requested; specimen with fixative or additives; Aptima® urine transport; Aptima® swab transport >30 days from collection; Aptima® swab specimen without a swab; cleaning swab (white-shaft swab) in Aptima® swab transport; any non−Gen-Probe® swab submitted in Aptima® transport device; transport device with multiple swabs; bloody or grossly mucoid specimens; bacterial swabs; specimen in ProbeTec™ UPT transport; ProbeTec™ Q-swabs.

Use

This test is intended to be used as an aid to the diagnosis of bacterial vaginosis (BV) in women with a clinical presentation consistent with this disorder.

Limitations

This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary.

Is LabCorp a FDA approved test?

This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary.

What is BV test?

This test is intended to be used as an aid to the diagnosis of bacterial vaginosis (BV) in women with a clinical presentation consistent with this disorder. The BV test utilizes semiquantitative PCR analysis of the three most predictive marker organisms (Atopobium vaginae, BVAB-2, and Megasphaera-1) to generate a total score that correlates directly with the presence or absence of BV. In this test system, samples with a total score of 0 to 1 are considered negative for BV, samples with a score of 3 to 6 positive for BV, and samples with a score of 2 indeterminate for BV. Detect the presence of Candida albicans and Candida glabrata DNA in vaginal samples as an aid to the diagnosis of vulvovaginal candidiasis in symptomatic women. Diagnosis of Trichomonas vaginalis infections. Detect and type active HSV shedding.

Expected Turnaround Time

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Collection

Vaginal swab: Collect vaginal fluid sample using the Gen-Probe® Aptima® swab by contacting the swab to the lower third of the vaginal wall and rotating the swab for 10 to 30 seconds to absorb fluid. Immediately place the swab into the transport tube and carefully break the swab shaft against the side of the tube. Tightly screw on the cap.

Storage Instructions

Maintain specimen at room temperature or refrigerate (2°C to 30°C). Stable at room temperature or refrigerated for 30 days.

Causes for Rejection

Specimen with incorrect patient identification; unlabeled specimen; inappropriate specimen transport conditions; specimens received after prolonged delay (usually >72 hours); specimen leaked in transit; specimen in expired transport or incorrect transport device; specimens with inappropriate source for test requested; specimen with fixative or additives; Aptima® urine transport; Aptima® swab transport >30 days from collection; Aptima® swab specimen without a swab; cleaning swab (white-shaft swab) in Aptima® swab transport; any non−Gen-Probe® swab submitted in Aptima® transport device; transport device with multiple swabs; bloody or grossly mucoid specimens; bacterial swabs; specimen in ProbeTec™ UPT transport; ProbeTec™ Q-swabs.

Use

This test is intended to be used as an aid to the diagnosis of bacterial vaginosis (BV) in women with a clinical presentation consistent with this disorder.

Limitations

This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary.

Useful For

Used to detect the presence of Candida albicans and Candida glabrata DNA in vaginal samples as an aid to the diagnosis of vulvovaginal candidiasis in symptomatic women. Also used in the diagnosis of Trichomonas vaginalis infections.

Specimen Required

Submit one vaginal swab in APTIMA vaginal or unisex swab. Ship refrigerate.

Test Classification

This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary.